.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Citi
McKesson
Mallinckrodt
Teva
Dow
Daiichi Sankyo
Argus Health
Merck
Covington

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065120

« Back to Dashboard
NDA 065120 describes TOBRAMYCIN SULFATE (PHARMACY BULK), which is a drug marketed by Hospira and Fresenius Kabi Usa and is included in two NDAs. It is available from one supplier. Additional details are available on the TOBRAMYCIN SULFATE (PHARMACY BULK) profile page.

The generic ingredient in TOBRAMYCIN SULFATE (PHARMACY BULK) is tobramycin sulfate. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

Summary for 065120

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 065120

Ingredient-typeAminoglycosides

Suppliers and Packaging for NDA: 065120

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOBRAMYCIN SULFATE (PHARMACY BULK)
tobramycin sulfate
INJECTABLE;INJECTION 065120 ANDA Fresenius Kabi USA, LLC 63323-307 63323-307-51 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 40MG BASE/ML
Approval Date:Nov 29, 2002TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Argus Health
McKinsey
Merck
AstraZeneca
Julphar
Healthtrust
Harvard Business School
UBS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot